J. Branagan

Comparison of investigator-delineated gross tumor volumes and quality assurance in pancreatic cancer: Analysis of the pretrial benchmark case for the SCALOP trial.

R. Abrams, J. Staffurth, E. Spezi, 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Reduction of interobserver variability (IOV) by FDG-PET–based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer.

C. Hurt, T. Brunner, S. Mukherjee, 2013 .